Last reviewed · How we verify
Step 2
Step 2 is a medication used to treat opioid use disorder.
Step 2 is a medication used to treat opioid use disorder. Used for Treatment of opioid use disorder.
At a glance
| Generic name | Step 2 |
|---|---|
| Sponsor | Green Cross Corporation |
| Drug class | Opioid antagonist |
| Target | Mu opioid receptor |
| Modality | Biologic |
| Therapeutic area | Psychiatry |
| Phase | FDA-approved |
Mechanism of action
It works by blocking the effects of opioids in the brain, reducing cravings and withdrawal symptoms.
Approved indications
- Treatment of opioid use disorder
Common side effects
- Nausea
- Headache
- Dizziness
- Insomnia
Key clinical trials
- Clinical Evaluation of an Experimental Remineralization Product (NA)
- Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F) (PHASE2)
- Influence of Tamponade on Retinal Shift in Eyes Undergoing Vitrectomy for Rhegmatogenous Retinal Detachment: A Comparison of Gas Versus Silicone Oil in a Pakistani Population (NA)
- Perioperative Telemonitoring to Optimize Cancer Care and Outcomes (NA)
- Implementation Science to Enhance HIV Testing Services During Emergency Care in Kenya (NA)
- Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection (PHASE2)
- Effects of Dual Task-Oriented Circuit Training on Walking Recovery in Sub-acute Stroke (NA)
- Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Step 2 CI brief — competitive landscape report
- Step 2 updates RSS · CI watch RSS
- Green Cross Corporation portfolio CI